Description

Enhertu is a medication used in the treatment of certain types of breast cancer and gastric cancer. It is an antibody-drug conjugate that targets HER2-positive cancer cells, delivering cytotoxic agents directly to them to inhibit tumor growth.

Interpreter Notes

Interpreters should be aware that the term 'Enhertu' may be used in various clinical settings, particularly in oncology. It is essential to maintain a formal register and avoid colloquial terms when discussing this medication. Be cautious of potential confusion with other cancer treatments that may have similar names.

Example Sentences

EN: The oncologist recommended Enhertu for the patient's HER2-positive breast cancer.

ES: El oncólogo recomendó Enhertu para el cáncer de mama HER2 positivo del paciente.

Common Interpreter Mistakes

Confusing Enhertu with other cancer medications; mispronouncing the name leading to misunderstandings; using informal language when discussing the treatment.